Brazil, Mexico access to expensive cancer drugs "improving"

Article Date: 12/04/2012 06:00
Brazil, Mexico access to expensive cancer drugs "improving"

Vacancy Search

Quick job search

Advanced Search

Latest News

Europe clears Simponi for non-radiographic axial spondyloarthritis

Europe clears Simponi for non-radiographic axial spondyloarthritis

Boehringer's Giotrif beats Roche's Tarceva on lung cancer survival

Boehringer's Giotrif beats Roche's Tarceva on lung cancer survival

Biogen signs $1bn ophthalmic pact with AGTC

Biogen signs $1bn ophthalmic pact with AGTC

Chancellor must up NHS cash or face risking patient care: King's Fund

Chancellor must up NHS cash or face risking patient care: King's Fund

NHS still behind its peers on key care indicators

NHS still behind its peers on key care indicators

Underwriters breathe a sigh of relief as IPOs tick up

If the first quarter had shown worrying signs of waning interest in new biotech flotations, the latest set of data should have investment bankers breathing more easily.

Interview – US placement reanimates Neovacs into lupus play

Coming off the year-end failure of its lead project, Neovacs provides more evidence that there are second chances in biotech if one can find the right risk-inclined investors. The French...

FDA to review Pfizer's once-daily Xeljanz for RA

FDA to review Pfizer's once-daily Xeljanz for RA

Sanofi's Lantus, Gilead's Harvoni welcomed to Japan

Sanofi's Lantus, Gilead's Harvoni welcomed to Japan

FDA approves new cystic fibrosis drug Orkambi

FDA approves new cystic fibrosis drug Orkambi
more news